NCT06545552View on ClinicalTrials.gov

Efficacy and Safety of a Dietary Supplement on Hair Growth and Hair Health in Female With Acute Telogen Effluvium

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

January 24, 2025

Study Completion Date

January 24, 2025

Conditions

Telogen EffluviumHealthy

Interventions

DIETARY_SUPPLEMENT

An oral formulation of green tea extract, bamboo shoot extract and selenium-enriched yeast

Hard shell capsule containing 280mg of the oral formulation

DIETARY_SUPPLEMENT

Placebo

Hard shell capsule containing maltodextrine

Trial Locations (1)

27028

Complife Italia srl, San Martino Siccomario

All Listed Sponsors

collaborator

Complife Italia Srl

INDUSTRY

lead

Activ'inside

INDUSTRY

NCT06545552 - Efficacy and Safety of a Dietary Supplement on Hair Growth and Hair Health in Female With Acute Telogen Effluvium | Biotech Hunter | Biotech Hunter